Augment: A Phase Iii Randomized Study Of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo In Patients With Relapsed/Refractory Indolent Non-Hodgkin LymphomaJohn P. Leonard,Marek Trněný,Koji Izutsu,Nathan H. Fowler,Xiaonan Hong,Jun Zhu,Huilai Zhang,Fritz Offner,Adriana Scheliga,Grzegorz S. Nowakowski,Antonio Pinto,Francesca Re,Laura Maria Fogliatto,Phillip Scheinberg,Ian W. Flinn,Cláudia Moreira,David Liu,Stacey Kalambakas,Pierre Fustier,Chengqing Wu,John G. GribbenBLOOD（2018）引用 14|浏览25暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
